facebook twitter linkedin
  • images/stories/slider.png
  • images/stories/slider2.png
  • images/stories/slider3.png
  • images/stories/slider4.png

NEWS RELEASES

  • Selvita shows 31% revenue growth in H1 2016

    Krakow, Poland - Aug 31, 2016 – Selvita, the largest drug discovery company in Central and Eastern Europe, has experienced a dynamic revenue growth in the first half of 2016. Net revenues from sales (excluding grants) amounted to PLN 22.7 MM, resulti…

    Read More...

  • FDA has accepted Selvita's IND application for the SEL24 Phase I/II clinical trial in AML

    Kraków, Poland, 18 August 2016 – Selvita (WSE:SLV), the largest drug discovery company in Central and Eastern Europe, has received an acceptance for its IND application from the U.S. Food and Drug Administration (FDA) for SEL24, the first compound to…

    Read More...

  • Selvita exhibits at ChemOutsourcing 2016

    Krakow, 17 August 2016 - Selvita will participate and exhibit at the upcoming Pharma ChemOutsourcing 2016 conference, which will take place 19 - 21 September 2016, in The Hilton Hotel in Parsippany, NJ.   ChemOutsourcing is the largest USA-based AP…

    Read More...